Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Asset Writedowns and Impairment (2016 - 2020)

Medifast's Asset Writedowns and Impairment history spans 7 years, with the latest figure at $48000.0 for Q4 2020.

  • For Q4 2020, Asset Writedowns and Impairment fell 88.81% year-over-year to $48000.0; the TTM value through Dec 2020 reached $7.0 million, up 0.69%, while the annual FY2020 figure was $556000.0, 84.72% down from the prior year.
  • Asset Writedowns and Impairment reached $48000.0 in Q4 2020 per MED's latest filing, down from $429000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $6.1 million in Q2 2016 to a low of $48000.0 in Q4 2020.
  • Average Asset Writedowns and Impairment over 5 years is $2.6 million, with a median of $429000.0 recorded in 2019.
  • Peak YoY movement for Asset Writedowns and Impairment: rose 3.12% in 2019, then crashed 88.81% in 2020.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $6.1 million in 2016, then changed by 0.0% to $6.1 million in 2017, then plummeted by 93.18% to $416000.0 in 2018, then grew by 3.12% to $429000.0 in 2019, then plummeted by 88.81% to $48000.0 in 2020.
  • Per Business Quant, the three most recent readings for MED's Asset Writedowns and Impairment are $48000.0 (Q4 2020), $429000.0 (Q4 2019), and $416000.0 (Q4 2018).